Spectacle Decentration to Augment Over-minus Therapy in Cases with Intermittent Exotropia
Abstract
Purpose: To evaluate the adding effect of inward decentration of concave spectacle lenses (adding a prismatic effect) on angle control in cases with distance intermittent exotropia (IXT) receiving over-minus therapy.Methods: Patients with myopia with IXT angles ≤25 and a Newcastle score (NCS) ≥5 were included. Patients were randomised into two groups. Group 1 received over-minus therapy. Group 2 received over-minus therapy with inward decentration of spectacle glasses to add a base out prism effect equal to one-third of the distance angle of deviation. Success was measured as the percentage of orthotropic cases or those with orthophoria or IXT with improved NCS ≤ 3 and tolerant to treatment. Patients were evaluated 3 months after initial treatment, 3 months after partial weaning and 18 months after complete weaning.Results: Sixty-four patients were included, with 32 in each group. The success rates of group 1 were 65.6%, 37.5%, and 31.3%, in group 2, the rates were 75%, 65.6%, and 65.6% for orthotropic cases or those with orthophoria or IXT with improved NCS ≤ 3, respectively. Moreover, NCS significantly improved in group 2 till last visit.Conclusion: Adding decentration to over-minus therapy can result in better control of small angle IXT and could be considered as a non-invasive and reversible therapy.
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.